Genetic testing for heritable mutations relating to colorectal and endometrial cancer are now available on MBS
25 May, 2020

The Royal College of Pathologists of Australasia (RCPA) is pleased to announce that genetic tests to identify heritable mutations, which increase the risk of developing colorectal and endometrial cancer, are now available on the Medicare Benefits Schedule (MBS). This addition to the MBS follows an application by the RCPA to the Medical Services Advisory Committee (MSAC).

Go Back

Page last updated:

Copyright © 2020 RCPA. All rights reserved.